166 related articles for article (PubMed ID: 27989931)
21. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.
DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers MED; Savani BN; Shaw BE; ;
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1493-1503. PubMed ID: 27184625
[TBL] [Abstract][Full Text] [Related]
22. National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation.
Stroncek D; Harvath L; Barrett J
Cytotherapy; 2002; 4(5):415-8. PubMed ID: 12479173
[No Abstract] [Full Text] [Related]
23. International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GM; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
Transplant Cell Ther; 2024 Apr; 30(4):349-385. PubMed ID: 38413247
[TBL] [Abstract][Full Text] [Related]
24. The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation.
Murphy EA; Ferguson SS; Omondi NA; Getzendaner LC; Gajewski JL; Goldstein GA; Wingard JR; Rizzo JD; Majhail NS
Biol Blood Marrow Transplant; 2010 Feb; 16(2):147-56. PubMed ID: 20142045
[TBL] [Abstract][Full Text] [Related]
25. Survivorship after allogeneic transplantation-management recommendations for the primary care provider.
Tichelli A; Rovó A
Curr Hematol Malig Rep; 2015 Mar; 10(1):35-44. PubMed ID: 25667128
[TBL] [Abstract][Full Text] [Related]
26. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
[TBL] [Abstract][Full Text] [Related]
27. Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.
Burns LJ; Abbetti B; Arnold SD; Bender J; Doughtie S; El-Jawahiri A; Gee G; Hahn T; Horowitz MM; Johnson S; Juckett M; Krishnamurit L; Kullberg S; LeMaistre CF; Loren A; Majhail NS; Murphy EA; Rizzo D; Roche-Green A; Saber W; Schatz BA; Schmit-Pokorny K; Shaw BE; Syrjala KL; Tierney DK; Ullrich C; Vanness DJ; Wood WA; Denzen EM
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1111-1118. PubMed ID: 29408289
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.
Armenian SH; Horak D; Scott JM; Mills G; Siyahian A; Berano Teh J; Douglas PS; Forman SJ; Bhatia S; Jones LW
Biol Blood Marrow Transplant; 2017 Apr; 23(4):700-705. PubMed ID: 28065839
[TBL] [Abstract][Full Text] [Related]
30. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Bishop MR; Alyea EP; Cairo MS; Falkenburg JH; June CH; Kröger N; Little RF; Miller JS; Pavletic SZ; Porter D; Riddell SR; van Besien K; Wayne AS; Weisdorf DJ; Wu R; Giralt S
Biol Blood Marrow Transplant; 2010 May; 16(5):563-4. PubMed ID: 20202482
[No Abstract] [Full Text] [Related]
31. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
[TBL] [Abstract][Full Text] [Related]
32. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
Gifford G; Sim J; Horne A; Ma D
Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.
Turcotte LM; Yingst A; Verneris MR
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1159-1166. PubMed ID: 27013015
[TBL] [Abstract][Full Text] [Related]
34. Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium.
Zhu W; Zhang J
Circ Res; 2017 May; 120(11):1709-1712. PubMed ID: 28546353
[No Abstract] [Full Text] [Related]
35. Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program.
Hahn T; Paplham P; Austin-Ketch T; Zhang Y; Grimmer J; Burns M; Balderman S; Ross M; McCarthy PL
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1968-1973. PubMed ID: 28782599
[TBL] [Abstract][Full Text] [Related]
36. A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.
Chaudhury S; Ayas M; Rosen C; Ma M; Viqaruddin M; Parikh S; Kharbanda S; Chiang KY; Haight A; Bhatia M; Guilcher G; Thompson A; Shenoy S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1695-1700. PubMed ID: 28627425
[TBL] [Abstract][Full Text] [Related]
37. Blood and marrow transplantation compensation: perspective in payer and provider relations.
Gajewski JL; Foote M; Tietjen J; Melson B; Simmons A; Champlin RE
Biol Blood Marrow Transplant; 2004 Jul; 10(7):427-32. PubMed ID: 15205664
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
Griffith LM; Pavletic SZ; Tyndall A; Bredeson CN; Bowen JD; Childs RW; Gratwohl A; van Laar JM; Mayes MD; Martin R; McSweeney PA; Muraro PA; Openshaw H; Saccardi R; Sandmaier BM; Forman SJ; Nash RA;
Biol Blood Marrow Transplant; 2005 Nov; 11(11):862-70. PubMed ID: 16275589
[No Abstract] [Full Text] [Related]
39. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
[TBL] [Abstract][Full Text] [Related]
40. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
